Loading…

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function : The total occlusion study of Canada (TOSCA)-2 trial

In the present study, we sought to determine whether opening a persistently occluded infarct-related artery (IRA) by percutaneous coronary intervention (PCI) in patients beyond the acute phase of myocardial infarction (MI) improves patency and indices of left ventricular (LV) size and function. Betw...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2006-12, Vol.114 (23), p.2449-2457
Main Authors: DZAVIK, Vladimir, BULLER, Christopher E, THOMAS, Boban, BUSZMAN, Pawel, VOZZI, Carlos, GLANZ, Anthony, COHEN, Eric A, MECIAR, Peter, DEVLIN, Gerald, MASCETTE, Alice, SOPKO, George, KNATTERUD, Genell L, LAMAS, Gervasio A, HOCHMAN, Judith S, RANKIN, James M, MANCINI, G. B. John, CANTOR, Warren J, CARERE, Ronald J, ROSS, John R, ATCHISON, Deborah, FORMAN, Sandra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the present study, we sought to determine whether opening a persistently occluded infarct-related artery (IRA) by percutaneous coronary intervention (PCI) in patients beyond the acute phase of myocardial infarction (MI) improves patency and indices of left ventricular (LV) size and function. Between May 2000 and July 2005, 381 patients with an occluded native IRA 3 to 28 days after MI (median 10 days) were randomized to PCI with stenting (PCI) or optimal medical therapy alone. Repeat coronary and LV angiography was performed 1 year after randomization (n=332, 87%). Coprimary end points were IRA patency and change in LV ejection fraction. Secondary end points included change in LV end-systolic and end-diastolic volume indices and wall motion. PCI was successful in 92%. At 1 year, 83% of PCI versus 25% of medical therapy-only patients had a patent IRA (P
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.106.669432